177 related articles for article (PubMed ID: 16317429)
1. Current management of treatment-induced bone loss in women with breast cancer treated in the United Kingdom.
Lester JE; Dodwell D; Horsman JM; Mori S; Coleman RE
Br J Cancer; 2006 Jan; 94(1):30-5. PubMed ID: 16317429
[TBL] [Abstract][Full Text] [Related]
2. Management of cancer-treatment-induced bone loss in postmenopausal women undergoing adjuvant breast cancer therapy: a Z-FAST update.
Brufsky A
Semin Oncol; 2006 Apr; 33(2 Suppl 7):S13-7. PubMed ID: 16730272
[TBL] [Abstract][Full Text] [Related]
3. Current opinion of aromatase inhibitor-induced arthralgia in breast cancer in the UK.
Din OS; Dodwell D; Winter MC; Mori S; Coleman RE
Clin Oncol (R Coll Radiol); 2011 Dec; 23(10):674-80. PubMed ID: 21788122
[TBL] [Abstract][Full Text] [Related]
4. Long-term implications of bone loss in breast cancer.
Aapro MS
Breast; 2004 Dec; 13 Suppl 1():S29-37. PubMed ID: 15585380
[TBL] [Abstract][Full Text] [Related]
5. Bone loss and the aromatase inhibitors.
Lester J; Coleman R
Br J Cancer; 2005 Aug; 93 Suppl 1(Suppl 1):S16-22. PubMed ID: 16100521
[TBL] [Abstract][Full Text] [Related]
6. Managing bone loss in women with early-stage breast cancer receiving aromatase inhibitors.
Brufsky AM
Clin Breast Cancer; 2007 Dec; 8 Suppl 1():S22-34. PubMed ID: 18282367
[TBL] [Abstract][Full Text] [Related]
7. Effect of denosumab on low bone mineral density in postmenopausal Japanese women receiving adjuvant aromatase inhibitors for non-metastatic breast cancer: 24-month results.
Nakatsukasa K; Koyama H; Ouchi Y; Ono H; Sakaguchi K; Matsuda T; Kato M; Ishikawa T; Yamada K; Yoshimura M; Koizumi K; Sakurai T; Shigematsu H; Takahashi S; Taira S; Suzuki M; Narui K; Niikura N; Hasegawa Y; Miura D; Konishi E; Taguchi T;
Breast Cancer; 2019 Jan; 26(1):106-112. PubMed ID: 30054855
[TBL] [Abstract][Full Text] [Related]
8. Aromatase inhibitor adjuvant chemotherapy of breast cancer results in cancer therapy induced bone loss.
Rinaldi RZ
Curr Osteoporos Rep; 2013 Mar; 11(1):61-4. PubMed ID: 23408144
[TBL] [Abstract][Full Text] [Related]
9. [Encounter of cancer cells with bone. Cancer treatment-induced bone loss : CTIBL].
Takahashi S
Clin Calcium; 2011 Mar; 21(3):447-53. PubMed ID: 21358067
[TBL] [Abstract][Full Text] [Related]
10. Optimisation of breast cancer patients' follow-up - potential way to improve cancer care in transitional countries.
Bošković L; Gašparić M; Petrić Miše B; Petković M; Gugić D; Ban M; Jazvić M; Dabelić N; Belac Lovasić I; Vrdoljak E
Eur J Cancer Care (Engl); 2017 Jul; 26(4):. PubMed ID: 27145728
[TBL] [Abstract][Full Text] [Related]
11. Reducing the risk for breast cancer recurrence after completion of tamoxifen treatment in postmenopausal women.
Jahanzeb M
Clin Ther; 2007 Aug; 29(8):1535-47. PubMed ID: 17919537
[TBL] [Abstract][Full Text] [Related]
12. The effects of adjuvant endocrine therapy on bone health in women with breast cancer.
Ramchand SK; Cheung YM; Yeo B; Grossmann M
J Endocrinol; 2019 Jun; 241(3):R111-R124. PubMed ID: 30991355
[TBL] [Abstract][Full Text] [Related]
13. Variation in early breast cancer systemic adjuvant therapy practice among UK oncologists with potential impact on patient benefit and the financial burden: national postal questionnaire survey.
Moe MM
Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):734-5. PubMed ID: 19656666
[No Abstract] [Full Text] [Related]
14. Evolution of breast cancer treatments: current options and quality-of-life considerations.
Fallowfield LJ
Eur J Oncol Nurs; 2004; 8 Suppl 2():S75-82. PubMed ID: 15590318
[TBL] [Abstract][Full Text] [Related]
15. Oncologists' recommendations for adjuvant therapy in hormone receptor-positive breast cancer patients of varying age and health status.
Naeim A; Wong FL; Pal SK; Hurria A
Clin Breast Cancer; 2010 Apr; 10(2):136-43. PubMed ID: 20353934
[TBL] [Abstract][Full Text] [Related]
16. Management of bone health in patients with cancer: a survey of specialist nurses.
Drudge-Coates L; van Muilekom E; de la Torre-Montero JC; Leonard K; van Oostwaard M; Niepel D; Jensen BT
Support Care Cancer; 2020 Mar; 28(3):1151-1162. PubMed ID: 31203509
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibitors in the adjuvant treatment of postmenopausal women with early breast cancer: Putting safety issues into perspective.
Conte P; Frassoldati A
Breast J; 2007; 13(1):28-35. PubMed ID: 17214790
[TBL] [Abstract][Full Text] [Related]
18. Cancer treatment-induced bone loss: pathophysiology and clinical perspectives.
Brufsky AM
Oncologist; 2008 Feb; 13(2):187-95. PubMed ID: 18305064
[TBL] [Abstract][Full Text] [Related]
19. Clinical review: Effect of endocrine therapies on bone in breast cancer patients.
Santen RJ
J Clin Endocrinol Metab; 2011 Feb; 96(2):308-19. PubMed ID: 21147884
[TBL] [Abstract][Full Text] [Related]
20. Topical estrogen prescribing patterns for urogenital atrophy among women with breast cancer: results of a national provider survey.
Richter LA; Han J; Bradley S; Lynce FC; Willey SC; Tefera E; Pollack CE
Menopause; 2019 Jul; 26(7):714-719. PubMed ID: 30939535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
